Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kosan Biosciences receives SBIR grant to develop production method for laulimalide

March 14, 2003

Transarterial 131I-lipiodol in HCC

March 13, 2003

Ariad focuses resources on anticancer candidates

March 13, 2003

Novel series of antiangiogenic tyrosine kinase inhibitors for cancer and other disorders

March 13, 2003

Novel agents for enhancing DNA-damaging antitumor activity

March 13, 2003

Quinoline Src kinase inhibitors in AstraZeneca pipeline

March 13, 2003

Enrollment completed in phase III trial of Aptosyn/Taxotere in NSCLC

March 12, 2003

Velcade NDA granted priority review

March 12, 2003

Novel antitumor ecteinascidins reported by Spanish research team

March 12, 2003

Gemin X claims novel compounds for cancer, viral infections and autoimmune diseases

March 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.